Publications by authors named "J M Baena-Canada"
Cross-sectional and longitudinal associations of adherence to WCRF/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study.
J Nutr Health Aging
August 2024
Article Synopsis
- - The study investigates how following cancer prevention guidelines from the WCRF/AICR affects the health-related quality of life (HRQL) in breast cancer survivors over a long period, specifically comparing their status at diagnosis and 7-12 years later.
- - Researchers analyzed data from 406 breast cancer survivors, collecting information on lifestyle, diet, physical activity, and HRQL using a scoring system based on WCRF/AICR recommendations.
- - Results indicate that higher adherence to these cancer prevention guidelines is linked to slight improvements in the physical aspect of HRQL over time, while no significant change was found in the mental HRQL domain.
Background: Implementing mammogram screening means that clinicians are seeing many breast cancers that will never develop metastases. The purpose of this study was to identify subgroups of breast cancer patients who did not present events related to long-term breast cancer mortality, taking into account diagnosis at breast screening, absence of palpability and axillary involvement, and genomic analysis with PAM50.
Patients And Methods: To identify them, a retrospective observational study was carried out selecting patients without any palpable tumor and without axillary involvement, and a genomic analysis was performed with PAM50.
Background And Objective: Reproductive history influences breast cancer risk. We analysed its association with tumour subtype and survival in premenopausal women.
Patients And Methods: Retrospective, observational study of premenopausal women with stage I-III breast carcinoma in the last 20 years.
Adjuvant trastuzumab in HER2+ breast cancer reduces recurrence and mortality, and has been the standard treatment since 2006. The objective was to analyze health outcomes in the real world. Observational, retrospective study of patients with HER2+ breast cancer, stages I-III, treated with adjuvant trastuzumab in the past 15 years in only one center and for the first time in Spain.
View Article and Find Full Text PDFBreast cancer (BC) survivors are advised to follow the WCRF/AICR cancer prevention recommendations, given their high risk of developing a second tumour. We aimed to explore compliance with these recommendations in BC survivors and to identify potentially associated clinical and sociodemographic factors. A total of 420 BC survivors, aged 31-80, was recruited from 16 Spanish hospitals.
View Article and Find Full Text PDF